Literature DB >> 12759128

Facilitation of electrical brain self-stimulation behavior by abused solvents.

Anton Bespalov1, Irina Sukhotina, Ivan Medvedev, Andrey Malyshkin, Irina Belozertseva, Robert Balster, Edwin Zvartau.   

Abstract

Animal models are needed to study the abuse-related behavioral and pharmacological effects of inhaled solvents. Previous studies have suggested that intracranial self-stimulation techniques may be successfully adapted for testing the effects of solvent exposure. The present study aimed to assess the effects of toluene, cyclohexane, acetone, and petroleum benzine (a widely used mixture of hexanes and heptanes) in rats trained to lever press or nose-poke for electrical stimulation delivered through electrodes implanted into the medial forebrain bundle. It was found that toluene, cyclohexane, and benzine but not acetone, increased rates of responding, particularly at the lower stimulation intensities. In another set of experiments utilizing an auto-titration procedure, all tested solvents significantly reduced self-stimulation thresholds. However, only for toluene and benzine were these effects observed at the exposure levels that did not impair rates of operant performance. There may not be such a clear separation of effects for acetone and cyclohexane. Thus, toluene and benzine appear to selectively affect brain reward systems in a manner similar to that for most other abused drugs. Data from intracranial self-stimulation studies of solvents may be useful in abuse potential assessment of individual compounds and for examining neural and behavioral processes involved in inhalant abuse.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759128     DOI: 10.1016/s0091-3057(03)00071-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.

Authors:  Ming-Huan Chan; Yi-Ling Tsai; Mei-Yi Lee; Astrid K Stoker; Athina Markou; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2015-06-06       Impact factor: 4.530

Review 2.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

3.  Cyclohexane produces behavioral deficits associated with astrogliosis and microglial reactivity in the adult hippocampus mouse brain.

Authors:  Tania Campos-Ordonez; David Zarate-Lopez; Alma Y Galvez-Contreras; Norma Moy-Lopez; Jorge Guzman-Muniz; Oscar Gonzalez-Perez
Journal:  Cell Mol Neurobiol       Date:  2014-11-30       Impact factor: 5.046

Review 4.  How addictive drugs disrupt presynaptic dopamine neurotransmission.

Authors:  David Sulzer
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

5.  Sarcosine attenuates toluene-induced motor incoordination, memory impairment, and hypothermia but not brain stimulation reward enhancement in mice.

Authors:  Ming-Huan Chan; Shiang-Sheng Chung; Astrid K Stoker; Athina Markou; Hwei-Hsien Chen
Journal:  Toxicol Appl Pharmacol       Date:  2012-10-12       Impact factor: 4.219

6.  The effects of inhaled acetone on place conditioning in adolescent rats.

Authors:  Dianne E Lee; Jennifer Pai; Uma Mullapudui; David L Alexoff; Richard Ferrieri; Stephen L Dewey
Journal:  Pharmacol Biochem Behav       Date:  2007-11-22       Impact factor: 3.533

7.  Assessment of reinforcement enhancing effects of toluene vapor and nitrous oxide in intracranial self-stimulation.

Authors:  Matthew E Tracy; Galina G Slavova-Hernandez; Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2013-11-02       Impact factor: 4.530

8.  Cyclohexane, a Potential Drug of Abuse with Pernicious Effects on the Brain.

Authors:  Tania Campos-Ordonez; Oscar Gonzalez-Perez
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.